
Investigations into the work of a former top neuroscientist at the National Institutes of Health have left the researcher, Eliezer Masliah, with 32 retractions to date. Fifteen of them came this year, as journals continue examining his work following allegations — and findings — of scientific misconduct.
Masliah was the director of neuroscience at the National Institute on Aging from 2016 until 2024, where he led the division overseeing a research portfolio worth nearly $2.6 billion a year. Before joining NIA, he was a professor at the University of California, San Diego. He is a coauthor on more than 800 papers, with much of his career focused on alpha-synuclein, a protein that plays a key role in Parkinson’s disease. His work has been cited by researchers over 147,000 times, according to Clarivate’s Web of Science, and includes work on the development of experimental immunotherapies and animal models to study neurodegenerative diseases and test potential treatments.
Masliah’s work was the focus of a 2024 article in Science by investigative journalist Charles Piller, who, with a team of sleuths, uncovered signs of data and image manipulation in over 130 of Masliah’s papers across the breadth of his career.
Continue reading Former NIH neuroscientist passes 30 retractions






